Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
Jan P. Nicolay, Karin Müller‐Decker, Anne Schroeder, et al.
Blood (2016) Vol. 128, Iss. 6, pp. 805-815
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL
Anja Schmitt, Wendan Xu, Philip Bucher, et al.
Blood (2021) Vol. 138, Iss. 10, pp. 871-884
Open Access | Times Cited: 122
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death
Maria Elena Mantione, Miriam Meloni, Ilenia Sana, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 20
Dimethyl fumarate, a two‐edged drug: Current status and future directions
Nathaniel Edward Bennett Saidu, Niloufar Kavian, Karen Leroy, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1923-1952
Closed Access | Times Cited: 129
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Jürgen Brück, Ralf Dringen, Adriana Amasuno, et al.
Experimental Dermatology (2018) Vol. 27, Iss. 6, pp. 611-624
Open Access | Times Cited: 104
The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects
Ulrich Mrowietz, Peter J. Morrison, Ina Suhrkamp, et al.
Trends in Pharmacological Sciences (2017) Vol. 39, Iss. 1, pp. 1-12
Closed Access | Times Cited: 90
Targeting IKK and NF-κB for Therapy
Joel Durand, Albert S. Baldwin
Advances in protein chemistry and structural biology (2017), pp. 77-115
Closed Access | Times Cited: 88
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 306-306
Open Access | Times Cited: 73
Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?
Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Novel potential pharmacological applications of dimethyl fumarate—an overview and update
Giorgia Bresciani, Federico Manai, Sergio Davinelli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4–MyD88 Complex
Balyn W. Zaro, Ekaterina V. Vinogradova, Daniel C. Lazar, et al.
The Journal of Immunology (2019) Vol. 202, Iss. 9, pp. 2737-2746
Open Access | Times Cited: 58
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P. Nicolay, Susanne Melchers, J. Albrecht, et al.
Blood (2023) Vol. 142, Iss. 9, pp. 794-805
Open Access | Times Cited: 21
Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling
Karsten Gülow, Deniz Tümen, Philipp Heumann, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6114-6114
Open Access | Times Cited: 8
Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications
Rebecca Seitz, Deniz Tümen, C Kunst, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1078-1078
Open Access | Times Cited: 7
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
Tingting Wang, Lingling Liu, Xuyong Chen, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 59
Targeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Martina Gatzka
Cancers (2018) Vol. 10, Iss. 6, pp. 155-155
Open Access | Times Cited: 52
Deregulation of JAK2 signaling underlies primary cutaneous CD8<sup>+</sup> aggressive epidermotropic cytotoxic T-cell lymphoma
Armando N. Bastidas Torres, Davy Cats, Jacoba J. Out‐Luiting, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 702-714
Open Access | Times Cited: 33
Dimethyl fumarate ameliorates acetaminophen-induced hepatic injury in mice dependent of Nrf-2/HO-1 pathway
Rehab S. Abdelrahman, Noha Abdel‐Rahman
Life Sciences (2018) Vol. 217, pp. 251-260
Closed Access | Times Cited: 46
The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Julia Scarisbrick, M. Bagot, Pablo L. Ortiz‐Romero
British Journal of Haematology (2020) Vol. 192, Iss. 4, pp. 683-696
Open Access | Times Cited: 33
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma
Helena Sorger, Saptaswa Dey, Pablo Vieyra-Garcia, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 12
Open Access | Times Cited: 20
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis
Arezoo Hosseini, Ali Masjedi, Behzad Baradaran, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 9943-9955
Closed Access | Times Cited: 37
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature
Cinzia Dello Russo, Kathryn A. Scott, Munir Pirmohamed
Pharmacology & Therapeutics (2020) Vol. 219, pp. 107710-107710
Closed Access | Times Cited: 31
Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
Yoelvis García‐Mesa, He N. Xu, Patricia J. Vance, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 416-416
Open Access | Times Cited: 24
GAPDH-Silence Microsphere via Reprogramming Macrophage Metabolism and eradicating Bacteria for Diabetic infection bone regeneration
Jiale Jin, Xiaowei Xia, Chengxin Ruan, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top